PATENT CLAIM ANALYSIS

Application Number: 16343271
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["546", "153000"]

Abstract:
The present application provides a quinolyl-substituted carboxylic acid compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, as well as a method for preparing the compound, a use of the compound, and a formulation containing the quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof. This type of compounds are inhibitors for AXL and/or VEGFR2 protein kinase, and can be used to treat diseases caused by abnormality of the two protein kinases, such as, tumor, etc.;

Claim (Index 11):
A use of the quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof according to  claim 1 , or a racemate or a enantiomer of the quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof, or a pharmaceutical composition, comprising the quinolyl-substituted carboxylic acid compound or the pharmaceuticals acceptable salt thereof or the racemate or the enantiomer, for treating a disease caused by abnormality of protein kinase, wherein the protein kinase is preferably AXL and or VEGFR2.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 100.0
- Lexical Diversity: 1.58621
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14345922', '13819560', '13308287', '10420466', '12228421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7854663678121047
- 35 USC 102 Novelty (BERT): 0.5166931217391992
- Combined Prediction Score: 0.7585890432048141
- Mean Citation Score: 286.6710240000001
- Max Citation Score: 328.88113
- Similarity Product: 249.04657229274213

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test